{
    "body": "Against which protein is the antibody used for immonostaining of Lewy bodies raised?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11005264", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10867800", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15854770", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11207422", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19272424", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22370907", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12722831", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16691119", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10787032", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9759660", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10822429", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10967182", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12536227", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9600226"
    ], 
    "ideal_answer": [
        "alpha-Synuclein is a presynaptic protein, which was identified as a specific component of Lewy bodies (LB) and Lewy neurites. Therefore, immunostaining for detecting the presence of Lewy bodies is carried out using antibodies against alpha-synuclein."
    ], 
    "exact_answer": [
        "alpha-Synuclein"
    ], 
    "concepts": [
        "http://www.uniprot.org/uniprot/SYUA_SERCA", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000906", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010300", 
        "http://www.disease-ontology.org/api/metadata/DOID:12217", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051844", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020961", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016631", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0003823"
    ], 
    "type": "factoid", 
    "id": "53189656b166e2b80600001c", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 117, 
            "text": "\u03b1-Synuclein is the major protein associated with Lewy body dementia, Parkinson's disease and multiple system atrophy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22370907", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 310, 
            "offsetInEndSection": 518, 
            "text": "With the aim to develop antibodies showing high specificity and sensitivity for disease-associated \u03b1-synuclein, synthetic peptides containing different amino acid sequences were used for immunization of mice.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22370907", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 387, 
            "text": "Parkinson's disease and dementia with Lewy bodies are very frequent neurological disorders of the elderly. Mutations in the alpha-synuclein (alphaSYN) gene cause Parkinson's disease, often associated with dementia. Neuropathologically these diseases are characterized by the presence of Lewy bodies and Lewy neurites, intraneuronal inclusions mostly composed of alphaSYN protein fibrils.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19272424", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 594, 
            "offsetInEndSection": 677, 
            "text": "Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16691119", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 294, 
            "text": "We immunohistochemically investigated the degeneration processes of the nigro-striatal and nigro-amygdaloid pathways and the relationship between the loss of dopaminergic neurons and Lewy bodies (LB) formation in the substantia nigra using 15 autopsied cases of dementia with Lewy bodies (DLB).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15854770", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 459, 
            "offsetInEndSection": 650, 
            "text": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15854770", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 166, 
            "text": "The major protein constituent of Lewy bodies (LBs), the pathological hallmark of Parkinson disease and dementia with Lewy bodies, is considered to be alpha-synuclein,", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12722831", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 167, 
            "offsetInEndSection": 251, 
            "text": "Recently, alpha-synuclein (alphaS) has been found to be a central constituent of LB.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12536227", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 456, 
            "offsetInEndSection": 824, 
            "text": "By having the antibody AFshp raised specifically to alpha-synuclein to label Parkinson disease-specific Lewy bodies and Lewy neurites as well as synaptic boutons containing the unaltered protein, an initial attempt is made to map the overall distribution pattern and describe the staining behavior of the immunoreactive punctae in select regions of the prosencephalon.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11207422", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 680, 
            "offsetInEndSection": 880, 
            "text": "Notably, carboxy-terminal alpha-syn epitopes were immunodominant in GCIs, but the entire panel of antibodies immunostained cortical Lewy bodies (LBs) in dementia with LBs brain with similar intensity.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11005264", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 994, 
            "offsetInEndSection": 1165, 
            "text": "Discrete immunostaining was demonstrated in NFTs and neuropil threads with various antibodies against phosphorylated tau, and in LBs with antibody against alpha-synuclein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10967182", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 223, 
            "text": "The identification of the alpha-synuclein gene on chromosome 4q as a locus for familial Lewy-body parkinsonism and of alpha-synuclein as a component of Lewy bodies has heralded a new era in the study of Parkinson's disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10867800", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 83, 
            "text": "Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10822429", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 358, 
            "offsetInEndSection": 524, 
            "text": "recent advances in immunostaining of alpha-synuclein have suggested the possible importance of cortical Lewy bodies (CLBs) in the brains of demented patients with PD.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10822429", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1012, 
            "offsetInEndSection": 1133, 
            "text": "CLBs positive for alpha-synuclein are highly sensitive (91%) and specific (90%) neuropathologic markers of dementia in PD", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10822429", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1314, 
            "offsetInEndSection": 1433, 
            "text": "CLBs detected by alpha-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10822429", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 61, 
            "text": "alpha-Synuclein immunoreactivity in dementia with Lewy bodies", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10787032", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 123, 
            "text": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10787032", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 609, 
            "offsetInEndSection": 738, 
            "text": "alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10787032", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 325, 
            "text": "The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9759660", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 326, 
            "offsetInEndSection": 725, 
            "text": "To better understand the distribution of NACP/alpha-synuclein and its fragments in the LB-bearing neurons and neurites, as well as to clarify the patterns of NACP/alpha-synuclein compartmentalization, we studied NACP/alpha-synuclein immunoreactivity using antibodies against the C-terminal, N-terminal, and NAC regions after Proteinase K and formic acid treatment in the cortex of patients with LBs.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9759660", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1656, 
            "offsetInEndSection": 1872, 
            "text": "Ultrastructural analysis revealed that NACP/alpha-synuclein immunoreactivity was diffusely distributed within the amorphous electrodense material in the LBs and as small clusters in the filaments of LBs and neurites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9759660", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1873, 
            "offsetInEndSection": 2023, 
            "text": "These results support the view that aggregated NACP/alpha-synuclein might play an important role in the pathogenesis of disorders associated with LBs.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9759660", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 157, 
            "text": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9600226", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 341, 
            "offsetInEndSection": 453, 
            "text": "PD brain demonstrated alpha-synuclein immunoreactivity in nigral Lewy bodies, pale bodies and abnormal neurites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9600226", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 526, 
            "offsetInEndSection": 651, 
            "text": "DLB cases demonstrated these findings as well as alpha-synuclein immunoreactivity in cortical Lewy bodies and CA2-3 neurites.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9600226", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 652, 
            "offsetInEndSection": 833, 
            "text": "These results suggest that, even in sporadic cases, there is an early and direct role for alpha-synuclein in the pathogenesis of PD and the neuropathologically related disorder DLB.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9600226", 
            "endSection": "abstract"
        }
    ]
}